JUAN SALAZAR: Open Payments
NPI 1922041995 · POPLAR BLUFF, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 7 payments from 5 companies in 2025. Trend: 2023 $752 · 2024 $919 · 2025 $781
Food & beverage: $781
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $244 |
| Axsome Therapeutics, Inc. | 2 | $157 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $131 |
| E.R. Squibb & Sons, L.L.C. | 1 | $126 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $123 |
Products named: INGREZZA, Auvelity, COBENFY, CAPLYTA.
Industry payments across MO — which companies pay providers there.
